연구용
제품 번호S7223
| 세포주 | 분석 유형 | 농도 | 배양 시간 | 제형 | 활성 설명 | PMID |
|---|---|---|---|---|---|---|
| baculovirus/Sf9 cells | Function assay | Inhibition of recombinant Activin A receptor type II-like kinase (ALK5) expressed in baculovirus/Sf9 cells, IC50=4 nM | 15317461 | |||
| HepG2 cells | Function assay | Stimulation of Transforming growth factor beta receptor I kinase in HepG2 cells, IC50=10 nM | 15317461 | |||
| Sf9 | Function assay | Inhibition of human ALK5 expressed in Sf9 insect cells using casein as substrate in presence of [gamma-33P]ATP, IC50 = 0.181 μM. | 28135685 | |||
| Sf9 | Function assay | Inhibition of mouse ABL expressed in Sf9 insect cells using GGEAIYAAPFKK as substrate in presence of [gamma-33P]ATP, IC50 = 21 μM. | 28135685 | |||
| HeLa | Function assay | 1 uM | 30 mins | Inhibition of ALK5 in serum starved human HeLa cells assessed as reduction in TGF-beta-induced SMAD2/3 nuclear transaction at 1 uM pre-incubated for 30 mins before TGF-beta stimulation for 30 mins by immunofluorescence analysis | 28135685 | |
| 클릭하여 더 많은 세포주 실험 데이터 보기 | ||||||
| 분자량 | 287.32 | 화학식 | C17H13N5 |
보관 (수령일로부터) | |
|---|---|---|---|---|---|
| CAS 번호 | 446859-33-2 | SDF 다운로드 | 원액 보관 |
|
|
| 동의어 | SJN 2511,ALK5 Inhibitor II | Smiles | CC1=NC(=CC=C1)C2=C(C=NN2)C3=NC4=C(C=C3)N=CC=C4 | ||
|
In vitro |
DMSO
: 57 mg/mL
(198.38 mM)
Water : Insoluble Ethanol : Insoluble |
|
In vivo |
|||||
1단계: 아래 정보 입력 (권장: 실험 중 손실을 고려하여 추가 동물 포함)
2단계: 생체 내 제형 입력 (이것은 계산기일 뿐 제형이 아닙니다. 용해도 섹션에 생체 내 제형이 없는 경우 먼저 당사에 문의하십시오.)
계산 결과:
작업 농도: mg/ml;
DMSO 원액 준비 방법: mg 약물 사전 용해 μL DMSO ( 원액 농도 mg/mL, 농도가 해당 약물 배치의 DMSO 용해도를 초과하는 경우 먼저 당사에 문의하십시오. )
생체 내 제형 준비 방법: 취하다 μL DMSO 원액, 다음 추가μL PEG300, 혼합하고 투명하게 한 다음 추가μL Tween 80, 혼합하고 투명하게 한 다음 추가 μL ddH2O, 혼합하고 투명하게 합니다.
생체 내 제형 준비 방법: 취하다 μL DMSO 원액, 다음 추가 μL 옥수수 기름, 혼합하고 투명하게 합니다.
참고: 1. 다음 용매를 추가하기 전에 액체가 투명한지 확인하십시오.
2. 용매를 순서대로 추가해야 합니다. 다음 용매를 추가하기 전에 이전 추가에서 얻은 용액이 투명한 용액인지 확인해야 합니다. 와동, 초음파 또는 뜨거운 물 중탕과 같은 물리적 방법을 사용하여 용해를 도울 수 있습니다.
| Targets/IC50/Ki |
TGFβR1(ALK5)
(Cell-free assay) 4 nM
|
|---|---|
| 시험관 내(In vitro) |
RepSox (E-616452) inhibits ATP binding to ALK5 and ALK5 autophosphorylation with IC50 of 23 nM and 4 nM, respectively. It also inhibits TGF-β induced cellular PAI-1 luciferase activity with IC50 of 18 nM. This compound is able to successfully replace Sox2 in reprogramming by inhibiting transforming growth factor-β (Tgf-β) signaling, which in turn induces Nanog expression. Effect of RepSox inducing reprogramming does not require chromatin remodeling. It is found to be efficient at generating iPSCs. |
| 키나아제 분석 |
ALK5 fluorescence polarization binding assay
|
|
Compound binding to ALK5 is tested on purified recombinant GST-ALK5 (residues 198-503). Displacement of rhodamine green fluorescently labeled ATP competitive inhibitor by different concentrations of test compounds is used to calculate a binding pIC50. GST-ALK5 is added to a buffer containing 62.5 mM Hepes, pH 7.5, 1 mM DTT, 12.5 mM MgCl2, 1.25 mM CHAPS, and 1 nM rhodamine green-labeled ligand so that the final ALK5 concentration is 10 nM based on active site titration of the enzyme. Forty microliters of the enzyme/ligand reagent is added to 384 well assay plates containing 1 μL of different concentrations of RepSox (E-616452). The plates are read immediately on a fluorescence reader with excitation, emission, and dichroic filters of 485, 530, and 505 nm, respectively. The fluorescence polarization for each well is calculated by the Acquest and is then imported into curve fitting software for construction of concentration-response curves.
|
|
| 생체 내(In vivo) |
When injected into blastocysts, RepSox (E-616452) is able to contribute to forming chimeric embryos in vivo. A one-day treatment with this compound is sufficient to replace transgenic Sox2. |
참조 |
|
| 방법 | 바이오마커 | 이미지 | PMID |
|---|---|---|---|
| Western blot |